Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Xcopri
Pharma
Daiichi Sankyo, Glenmark, Serum-Biocon—Fierce Pharma Asia
Daiichi tripled Enhertu sales in its last fiscal year but had its leukemia drug delayed at the FDA. Glenmark settled an antitrust lawsuit. Plus more.
Angus Liu
Apr 28, 2023 8:35am
SK brings rainstorm to neurology event to push epilepsy drug
Apr 24, 2023 9:05am
J&J-Legend, Junshi, Vir-WuXi and more—Fierce Pharma Asia
May 27, 2022 9:53am
SK Life Sci kicks Xcopri sales into high gear with new campaign
May 24, 2022 7:37am
Social media mavens join SK Life’s latest epilepsy awareness ads
Aug 4, 2021 9:00am
SK Life’s dual TV ads for Xcopri target both docs and patients
May 11, 2021 10:25am
